Drugs Firm Awarded Vaccine Contract
June 20, 2008
THE Department of Health has awarded a contract to provide the vaccine against cervical cancer to pharmaceutical giant GlaxoSmithKline.
Cervarix is the name of the vaccine made by the drugs firm.
The HPV (human papillomavirus) vaccine will be offered to all girls aged 12 to 13 across the UK, including Coventry and Warwickshire, from September.
The contract is to supply the vaccine that protects against cervical cancer and pre-cancerous cell changes in the cervix caused by HPV viruses.
The vaccine will guard against the two strains of the HPV virus which cause 70 per cent of cases of cervical cancer.
(c) 2008 Coventry Evening Telegraph. Provided by ProQuest Information and Learning. All rights Reserved.